Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (18)

2023

  1. Ubiquitin proteomics identifies RNA polymerase I as a target of the Smc5/6 complex

    Cell Reports, Vol. 42, Núm. 5

2017

  1. Multilayer OMIC Data in medullary thyroid carcinoma identifies the STAT3 pathway as a potential therapeutic target in RETM918T Tumors

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1334-1345

2016

  1. Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies

    EBioMedicine, Vol. 10, pp. 137-149

2015

  1. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy

    Cell Death and Differentiation, Vol. 22, Núm. 11, pp. 1742-1753

  2. The CHEMDNER corpus of chemicals and drugs and its annotation principles

    Journal of Cheminformatics, Vol. 7

2014

  1. CheNER: Chemical named entity recognizer

    Bioinformatics, Vol. 30, Núm. 7, pp. 1039-1040

2013

  1. Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

    American Journal of Pathology, Vol. 182, Núm. 2, pp. 350-362

  2. Level of HER2 gene amplification predicts response and overall survival in her2-positive advanced gastric cancer treated with trastuzumab

    Journal of Clinical Oncology, Vol. 31, Núm. 35, pp. 4445-4452

2012

  1. Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

    Oncogene, Vol. 31, Núm. 35, pp. 3961-3972

  2. Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

    Human Pathology, Vol. 43, Núm. 7, pp. 1103-1112

2011

  1. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1

    PLoS ONE, Vol. 6, Núm. 7

  2. Smc5 flies solo

    Cell Cycle

2010

  1. Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis

    Endocrine-Related Cancer, Vol. 17, Núm. 1, pp. 7-16

2008

  1. Transforming pathways unleashed by a HDAC2 mutation in human cancer

    Oncogene, Vol. 27, Núm. 28, pp. 4008-4012

2006

  1. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

    Nature Genetics, Vol. 38, Núm. 5, pp. 566-569

  2. PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations

    Human Pathology, Vol. 37, Núm. 11, pp. 1465-1472

2005

  1. Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

    Modern Pathology, Vol. 18, Núm. 5, pp. 719-727

  2. Survivin expression in endometrial carcinoma: A tissue microarray study with correlation with PTEN and STAT-3

    International Journal of Gynecological Pathology, Vol. 24, Núm. 3, pp. 247-253